Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityNo recent work listed

Silvia Matilde Zanon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6475-531X; OpenAlex author ID A5063821971. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2016: 2 papers · 2017: 2 papers · 2018: 4 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers

Papers 12

  1. Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients. Co-author DOI 10.1007/s00280-020-04190-1↗
  2. Multidrug regimens for treatment of older patients with metastatic pancreatic cancer. Co-author DOI 10.1016/j.dld.2020.06.006↗
  3. Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00280-020-04047-7↗
  4. Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives. Co-author DOI 10.1016/j.ctrv.2018.10.013↗
  5. A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreati… First author DOI 10.1016/j.ejca.2018.07.007↗
  6. Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial. Co-author DOI 10.1016/s2468-1253(18)30081-5↗
  7. Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial. First author DOI 10.1016/s2468-1253(18)30196-1↗
  8. Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma. Co-author DOI 10.1053/j.seminoncol.2018.05.004↗
  9. Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. First author DOI 10.1093/annonc/mdx495↗
  10. The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective. Last author DOI 10.4103/eus.eus_62_17↗
  11. Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy? Co-author DOI 10.1016/j.ejso.2016.06.398↗
  12. Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic… Co-author DOI 10.1038/bjc.2016.209↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michele Reni · 12 shared papers, 2016–2021 · strength 1.04
  2. Umberto Peretti · 7 shared papers, 2017–2021 · strength 0.70
  3. Luca Gianni · 8 shared papers, 2016–2021 · strength 0.65
  4. Marina Macchini · 6 shared papers, 2018–2021 · strength 0.59
  5. Marta Chiaravalli · 6 shared papers, 2017–2021 · strength 0.49
  6. Gianpaolo Balzano · 7 shared papers, 2016–2020 · strength 0.47
  7. Massimo Falconi · 7 shared papers, 2016–2020 · strength 0.47
  8. Claudio Doglioni · 6 shared papers, 2016–2021 · strength 0.42
  9. Paolo Giorgio Arcidiacono · 5 shared papers, 2016–2020 · strength 0.35
  10. Paolo Passoni · 4 shared papers, 2016–2021 · strength 0.29
  11. Giulia Orsi · 2 shared papers, 2020–2021 · strength 0.22
  12. Domenico Tamburrino · 2 shared papers, 2020–2021 · strength 0.22
  13. Stefano Cascinu · 2 shared papers, 2016–2021 · strength 0.17
  14. Stefano Partelli · 2 shared papers, 2016–2018 · strength 0.12
  15. Giulio Belfiori · 1 shared paper, 2021 · strength 0.11
  16. Sabrina Gloria Giulia Testoni · 1 shared paper, 2021 · strength 0.11
  17. Gemma Rossi · 1 shared paper, 2021 · strength 0.11
  18. Stefano Crippa · 2 shared papers, 2016–2017 · strength 0.11
  19. Andrew L. Coveler · 1 shared paper, 2018 · strength 0.11
  20. David Bing Zhen · 1 shared paper, 2018 · strength 0.11
  21. Elena Gabriela Chiorean · 1 shared paper, 2018 · strength 0.11
  22. Stefania Mosconi · 1 shared paper, 2018 · strength 0.07
  23. Alessandro Zerbi · 1 shared paper, 2018 · strength 0.07
  24. Domenico Pinelli · 1 shared paper, 2018 · strength 0.07
  25. Kalliopi Andrikou · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.